Inventor
Rebecca Casaubon
Inventor
Cambridge, MA, US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes25%
PatentTitleYear
10,590,135Substituted bridged urea analogs as sirtuin modulators20209,957,271Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators20189,834,558Substituted bridged urea analogs as sirtuin modulators20179,765,075'Substituted bridged urea analogs as sirtuin modulators'20178,518,958'Pyrido [2,3-D] pyrimidines and their use as kinase inhibitors'20138,232,283'Raf inhibitors'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012–2013Patents assigned to CASAUBON REBECCA (2)· patent assignee history
2012–2013Patents assigned to FORMA THERAPEUTICS INC (2)· patent assignee history
2012–2013Patents assigned to KLUGE ARTHUR F (2)· patent assignee history
2012–2013Patents assigned to VOGT JOACHIM (2)· patent assignee history
2012–2018Based in Cambridge, MA, US· patent location history
2013Based in Chestnut Hill, MA, US· patent location history
2017–2020Patents assigned to GLAXOSMITHKLINE LLC (4)· patent assignee history
2020Based in Garnet Valley, PA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GLAXOSMITHKLINE LLC | 4 | 2017–2020 |
| CASAUBON REBECCAself | 2 | 2012–2013 |
| FORMA THERAPEUTICS INC | 2 | 2012–2013 |
| KLUGE ARTHUR F | 2 | 2012–2013 |
| VOGT JOACHIM | 2 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Cambridge, Massachusetts, US | 4 | 2012–2018 |
| Garnet Valley, Pennsylvania, US | 1 | 2020 |
| Chestnut Hill, Massachusetts, US | 1 | 2013 |